Articles related to CHILD & ADOLESCENT PSYCHIATRY

Johns Hopkins psychiatrists are spearheading a novel educational initiative, ADAP Jr. High, to address the critical gap in middle schoolers’ understanding of anxiety and depression, offering structured lessons and coping strategies to empower young students.

This study emphasizes the potential of MSK1 methylation levels and executive function as key indicators in predicting suicidal ideation among adolescents with major depressive disorder, providing a new dimension to our understanding of suicide risk factors in this age group.

Recent findings indicate a significant association between SSRI use in children and delayed puberty, with an odds ratio of 1.44. This underscores the importance of considering potential developmental impacts when prescribing these medications.

This case underscores the importance of understanding PANDAS and its management. Despite multiple rounds of treatment including antibiotics, intravenous immunoglobulin treatment (IVIG), plasmapheresis, antipsychotics, mood stabilizers, antidepressants/anxiolytics, adenotonsillectomy, individual psychotherapy, and partial hospitalization programs, the patient’s condition remained resistant.

The recent surge in ADHD medication-related errors is a pressing concern that demands immediate attention from healthcare providers. Learn how you can minimize risks and improve patient safety.

Discover how viloxazine ER could offer a new avenue for enhancing ADHD treatment efficacy in pediatric patients with inadequate response to stimulants.